MTOR and lung carcinoma: mTOR pathway members and eIFs are overexpressed in malignancies, such as squamous cell carcinoma of the head and neck, cancer of the lung, thyroid, breast and other cancer types (Wang et al. 2012; Gantenbein et al. 2018).